All OTC Ingredient TEAs Get Review Deadlines In Senate Draft Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
Senate HELP Committee leaders’ draft bill expands on changes in the House’s Sunscreen Innovation Act by requiring deadlines for FDA review of all OTC ingredient TEAs. Chairman Harkin and other HELP members propose setting “reasonable” deadlines for TEA reviews.